Consano Bio, Inc.
Biotechnology · BURLINGTON, MA
BiotechnologySEC Form D
Consano Bio, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 20, 2026, reporting $34,824,466 raised toward a $48,858,795 offering.
Incorporated in Delaware and based in BURLINGTON, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Consano Bio, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Andrew HallExecutive Officer · Director
- Jennifer SchmitkeExecutive Officer
- Doug Vander WeideDirector
- Christopher CentenoDirector
- Bill AbbingtonDirector
- Jerome AdamsDirector
- Michael PedeDirector
- Joe SchieslDirector
- John ConwayDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised